New study monitors heart risks in rare genetic disease
NCT ID NCT05063435
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 30 people with mucopolysaccharidoses (MPS) over three years to see how their heart and arteries change. Researchers use neck ultrasounds and blood tests to measure artery thickness, stiffness, and signs of inflammation. The goal is to better understand cardiovascular risks in MPS, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how MPS affects the heart and blood vessels over time, guiding future treatments.
- What could go wrong
- This is an observational study with only 30 participants, so findings may not apply to all MPS patients. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Orange County
Orange, California, 92868, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a hot bath after exercise help heal the heart?
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Grape powder may help aging immune systems — a trial puts it to the test
- A simple blood pressure cuff trick could shield the heart in kidney disease
- Can a sedative help rebuilt tissue survive after cancer surgery?